Original language | English |
---|---|
Pages (from-to) | 1397-1401 |
Number of pages | 5 |
Journal | Blood |
Volume | 129 |
Issue number | 10 |
DOIs | |
State | Published - Mar 9 2017 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Blood, Vol. 129, No. 10, 09.03.2017, p. 1397-1401.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapy
AU - Duncavage, Eric J.
AU - Uy, Geoffrey L.
AU - Petti, Allegra A.
AU - Miller, Christopher A.
AU - Lee, Yi Shan
AU - Tandon, Bevan
AU - Gao, Feng
AU - Fronick, Catrina C.
AU - O'Laughlin, Michelle
AU - Fulton, Robert S.
AU - Wilson, Richard K.
AU - Jacoby, Meagan A.
AU - Cashen, Amanda F.
AU - Wartman, Lukas D.
AU - Walter, Matthew J.
AU - Westervelt, Peter
AU - Link, Daniel C.
AU - DiPersio, John F.
AU - Ley, Timothy J.
AU - Welch, John S.
N1 - Funding Information: The authors thank Greg Malnassy, Nichole Helton, and the Washington University Tissue Procurement Core for sample storage and sample preparation, and Theresa Fletcher, Megan Haney, Shannon Kramer, Sharon Heath, Kierstin Luber, Megan Janke, and Paige Schnoebelen for assistance in patient enrollment, sample collection, and clinical data processing. This work was supported by a National Institutes of Health National Cancer Institute Acute Myeloid Leukemia (AML)-Specialized Programs of Research Excellence (P50 CA171963), the Genomics of AML Program Project grant (P01 CA101937), and the Alliance for Clinical Trials in Oncology Foundation (G.L.U.).
PY - 2017/3/9
Y1 - 2017/3/9
UR - http://www.scopus.com/inward/record.url?scp=85015152527&partnerID=8YFLogxK
U2 - 10.1182/blood-2016-10-745273
DO - 10.1182/blood-2016-10-745273
M3 - Letter
C2 - 28082444
AN - SCOPUS:85015152527
SN - 0006-4971
VL - 129
SP - 1397
EP - 1401
JO - Blood
JF - Blood
IS - 10
ER -